An upper gastrointestinal bleeding detection kit based on G4 chain and heme catalytic activity
By utilizing the catalytic activity of the G4 chain and heme, a detection kit is developed that solves the false negative problem in the detection of upper gastrointestinal bleeding in existing technologies, and achieves accurate detection in an acidic environment by taking advantage of the catalytic activity of the G4 chain and heme to form a complex.
Patent Information
- Application Number
- CN202410959723.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-17
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-07-17
AI Technical Summary
In existing technologies, when red blood cells are detected by binding hemoglobin to corresponding antibodies, the strong acidity of gastric juice and the food residue in vomit can interfere with the colloidal gold detection results, leading to a high false negative rate and a lack of direct detection methods for upper gastrointestinal bleeding.
A detection kit based on the catalytic activity of G4 chain and heme was used. The complex formed by the G4 chain and heme has HRP-like catalytic activity. The reaction of H2O2 and TMB solution resulted in color development, and qualitative and quantitative detection was performed by combining it with a semi-quantitative colorimetric card.
It enables accurate detection of upper gastrointestinal bleeding in an acidic environment, avoiding interference from food residue and gastric acid, and providing more accurate test results.
Smart Images

Figure CN118501431B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of bleeding detection kits, and in particular to an upper gastrointestinal bleeding detection kit based on G4 chain body and heme catalytic activity. Background Art
[0002] Vomitus occult blood test can be used to screen for upper gastrointestinal bleeding and tumors. For patients with unexplained symptoms and signs such as upper abdominal pain, upper abdominal tenderness, palpitations, sweating, vomiting, anemia, increased heart rate, and decreased blood pressure, vomitus should be tested for occult blood after excluding patients who have not taken iron or bismuth agents within 1 week and have not eaten or drunk water within 8 hours. A positive vomitus occult blood test indicates that the patient has upper gastrointestinal bleeding.
[0003] At present, when upper gastrointestinal bleeding is suspected, there is no direct vomitus detection method in clinical practice. Fecal occult blood detection is often used to determine whether there is bleeding, that is, the colloidal gold monoclonal antibody method (colloidal gold method for short), which detects red blood cells by binding hemoglobin to the corresponding antibody. However, due to the strong acidity of gastric juice, hemoglobin in bleeding specimens is often destroyed, and the chemical composition of food residues in vomitus and its own strong acidity often affect the results of colloidal gold detection. Therefore, this method often produces false negatives when detecting occult blood in gastric juice or vomitus. Summary of the invention
[0004] The purpose of the present invention is to solve the problem that in the prior art, red blood cells are detected by combining hemoglobin with corresponding antibodies, but due to the strong acidity of gastric juice, hemoglobin in bleeding specimens is often destroyed, and the chemical components in food residues in vomitus and its own strong acidity often affect the results of colloidal gold detection. Therefore, this method often produces false negatives when detecting occult blood in gastric juice or vomitus. A detection kit for upper gastrointestinal bleeding based on G4 chain and heme catalytic activity is proposed.
[0005] In order to achieve the above object, the present invention adopts the following technical solutions:
[0006] An upper gastrointestinal bleeding detection kit based on G4 chain body and heme catalytic activity, comprising:
[0007] A sampling device, the sampling device is composed of a sampling tube and a sampling bottle, and the sampling bottle contains Tris-EDTA buffer;
[0008] A detection device, comprising a detection reagent, a reaction cup, a positive quality control reagent and a semi-quantitative detection colorimetric card;
[0009] The detection reagent includes a reaction reagent and a color developing reagent, and the reaction reagent and the color developing reagent are respectively loaded in two detection reagent storage bottles;
[0010] The reaction cup includes a sample cup to be tested and a positive cup, and the bottom of each cup is coated with a G4 chain unit;
[0011] The positive quality control reagent is a mixture of 100 μmol / L standard hemoglobin and 1 mmol / L Tris-EDTA buffer, which is loaded in a light-proof positive quality control bottle.
[0012] Preferably, the reaction reagent is H2O2 solution, and the color developing reagent is TMB solution.
[0013] Preferably, the semi-quantitative detection colorimetric card can display the color development results after the reaction of 8 different concentration gradients of hemoglobin (0, 0.001, 0.01, 0.1, 1, 10, 100, 1000 mmol / L) with 10 mmol / L G4 chain, as well as the corresponding bleeding equivalent, result grade and clinical description.
[0014] Preferably, the concentration of the Tris-EDTA buffer in the sampling bottle is 1 mmol / L; the concentration of the H2O2 solution is 5 mol / L; and the concentration of the TMB solution is 20 mmol / L.
[0015] Preferably, the volume of the reaction cup is 500 μL; the content of the G4 chain unit is 500 nmol; and the content of the Tris-EDTA buffer in the sampling bottle is 990 μL.
[0016] Preferably, the G4 chain unit is a double G4 chain unit DNA, and its DNA sequence is 5'-AGGGTACCTAGGGTACCTA-3', as shown in SEQ ID NO:1.
[0017] A method for using an upper gastrointestinal bleeding detection kit based on G4 chain and heme catalytic activity, comprising the following steps:
[0018] Step 1) Use a sampling tube to collect patient samples, dilute the samples in a sampling bottle, take 50 μL of sample dilution and place it in the sample cup to be tested, and at the same time take 50 μL of positive quality control reagent and place it in the positive cup;
[0019] Step 2) Let the sample cup and the positive cup stand at room temperature for 30 minutes;
[0020] Step 3) Add 25 μL of reaction reagent and 25 μL of colorimetric reagent to the sample cup and the positive cup, mix by pipetting for 15 min. If the positive cup displays dark blue, it proves that all reagents in this test are under control and the test results are reliable. At this time, observe the sample cup to be tested;
[0021] Step 4) According to the color in the sample cup to be tested, the semi-quantitative test colorimetric card is used to determine whether the patient has upper gastrointestinal bleeding, which is divided into qualitative testing and quantitative testing;
[0022] The qualitative test is: if it is displayed as colorless and transparent, it indicates that no hemoglobin is detected in the patient's sample, no blood components, and no upper gastrointestinal bleeding; if it is displayed as blue, it indicates that the patient's sample contains hemoglobin, blood components are detected, and the patient has upper gastrointestinal bleeding;
[0023] The quantitative test is as follows: if the color is similar to the concentration of 0.001 mmol / L, it is judged as "±", and the patient may have upper gastrointestinal bleeding; if the color is similar to the concentration of 0.01 mmol / L, it is judged as "+", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥5 mL, and the patient has positive fecal occult blood; if the color is similar to the concentration of 0.1 mmol / L, it is judged as "++", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥50 mL, and the patient can observe black stool; if the color is similar to the concentration of 1 mmol / L, it is judged as "+++", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥500 mL, and the patient has clinical manifestations such as vomiting blood, general fatigue, and hypotension; if the color is similar to the concentration of 10 mmol / L and above, it is judged as "++++", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥30% of the total blood volume, and the patient may be in shock at any time.
[0024] Preferably, the patient sample is vomitus, gastric juice or upper gastrointestinal tract lavage fluid of the patient.
[0025] Compared with the prior art, the present invention has the following beneficial effects:
[0026] Based on the HRP-like catalytic activity of the G4 chain / heme complex, the present invention proposes an upper gastrointestinal bleeding detection kit based on the catalytic activity of the G4 chain and heme. The application of the kit can solve the problems of the lack of current clinical upper gastrointestinal bleeding detection methods and the low reliability of the results caused by many interference factors in alternative methods. Compared with the fecal occult blood colloidal gold detection in the prior art, the detection results of the kit of the present invention are more accurate, and the influence of the acidic environment on the detection results is avoided. A more accurate and reliable detection kit for detecting upper gastrointestinal bleeding can be established clinically. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 It is a schematic diagram of the composition of the upper gastrointestinal bleeding detection kit based on the catalytic activity of G4 chain body / heme;
[0028] Figure 2 Schematic diagram of a colorimetric card for semi-quantitative detection;
[0029] Figure 3Schematic diagram of the operation flow of the upper gastrointestinal bleeding detection kit based on G4 chain / heme catalytic activity.
[0030] In the figure: 1. Sampling device; 2. Detection device; 3. Sampling tube; 4. Sampling bottle; 5. Reaction reagent; 6. Colorimetric reagent; 7. Sample cup to be tested; 8. Positive cup; 9. Positive quality control reagent; 10. Semi-quantitative detection colorimetric card. DETAILED DESCRIPTION
[0031] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments.
[0032] like Figure 1-Figure 3 As shown, an upper gastrointestinal bleeding detection kit based on G4 chain body and heme catalytic activity comprises:
[0033] A sampling device 1, wherein the sampling device 1 is composed of a sampling tube 3 and a sampling bottle 4. The sampling tube 3 is composed of a plastic pipette tip and a cylindrical plastic tube with a length of about 31.84 mm and a diameter of 2 mm at the bottom. The tube body of the sampling tube 3 is marked with 50 μL and 10 μL scale lines from top to bottom. The sampling bottle 4 is a plastic bottle with a height of about 50 mm and a diameter of about 10 mm, containing 990 μL of 1 mmol / L Tris-EDTA (TE) buffer. The TE buffer has the function of preserving hemoglobin. The concentration of 1 mmol / L is used to keep the solution at a low osmotic pressure to further break up the red blood cells in the upper digestive tract specimen. The sampling bottle contains Tris-EDTA buffer;
[0034] A detection device 2, comprising a detection reagent, a reaction cup, a positive quality control reagent 9 and a semi-quantitative detection colorimetric card 10;
[0035] The detection reagent includes a reaction reagent 5 and a colorimetric reagent 6, which are respectively loaded in two detection reagent storage bottles; the detection reagent storage bottles are composed of a sample loading device and a reagent bottle. The sample loading device is also composed of a plastic pipette tip and a cylindrical plastic tube with a length of about 31.84 mm and a diameter of 2 mm below, and a 25 μL scale line is marked on the sample loading tube. The sampling bottle is a plastic bottle with a height of about 50 mm and a diameter of about 10 mm, containing a reaction reagent 5 or a colorimetric reagent 6. The reaction reagent 5 is a 5 mol / L H2O2 solution (reaction substrate); the colorimetric reagent 6 is a 20 mmol / L TMB (tetramethylbenzidine) solution (colorimetric substrate).
[0036] The reaction cup includes a sample cup 7 and a positive cup 8, both of which are coated with 500 nmol dry powder of the G4 chain sequence at the bottom. The reaction cup is 12.73 mm high, 5 mm in bottom diameter, and has a total volume of about 500 μL. The reference range of 500 nmol G4 chain is 120-160 g / L for normal human whole blood hemoglobin. The molecular weight of hemoglobin is 64,000, so the normal human hemoglobin concentration is 1.875-2.5 mmol / L. One unit of hemoglobin contains 4 units of heme, so the normal human whole blood hemoglobin concentration is about 7.5-10 mmol / L. One unit of G4 chain can bind to 2 units of heme. The present invention uses a double G4 chain unit DNA (specifically: 5'-AGGGTACCTAGGGTACCTA-3', as shown in SEQ ID NO: 1), so one double G4 chain unit can bind to 4 units of heme. Therefore, if the patient's vomitus is whole blood, the required G4 chain concentration is at least 1.875~2.5 mmol / L. Consider the dilution effect after sampling (1:100 dilution). In order to ensure that the reaction system has enough G4 chains, the amount of G4 chains in the reaction cup is finally determined to be 500 nmol, so that it reaches 10 mmol / L after adding 50 μL of sample and dissolving, which is 400 times the actual required amount;
[0037] The positive quality control reagent 9 is a mixture of 100 μmol / L standard hemoglobin and 1 mmol / L Tris-EDTA buffer, which is loaded in a light-proof positive quality control bottle. The positive quality control bottle is a brown plastic bottle (light-proof) and consists of a sample adding device and a reagent bottle. The sample adding device also consists of a plastic pipette tip and a cylindrical plastic tube with a length of about 31.84 mm and a diameter of 2 mm below. The sample adding tube is marked with a 50 μL scale line.
[0038] In this embodiment, the semi-quantitative detection colorimetric card 10 can display the color development results after the reaction of hemoglobin with 8 different concentration gradients of 0, 0.001, 0.01, 0.1, 1, 10, 100, and 1000 mmol / L, as well as the corresponding bleeding equivalent, result grade and clinical description. The semi-quantitative detection colorimetric card 10 is a color plastic-sealed instruction manual, which contains the color development results after the reaction of hemoglobin with 8 different concentration gradients of 0, 0.001, 0.01, 0.1, 1, 10, 100, and 1000 mmol / L, as well as the corresponding bleeding equivalent, result grade and clinical description.
[0039] This example also proposes a method for using an upper gastrointestinal bleeding detection kit based on G4 chain and heme catalytic activity, comprising the following steps:
[0040] Step 1) Use the sampling tube 3 to collect the patient sample, place the sample in the sampling bottle 4 for dilution, take 50 μL of the sample dilution solution and place it in the sample cup 7 to be tested, and at the same time take 50 μL of the positive quality control reagent 9 and place it in the positive cup 8;
[0041] Step 2) leaving the sample cup 7 and the positive cup 8 at room temperature for 30 minutes;
[0042] Step 3) Add 25 μL of reaction reagent 5 and 25 μL of colorimetric reagent 6 to the sample cup 7 and the positive cup 8, and mix them by pipetting for 15 min. If the positive cup 8 is displayed as dark blue, it proves that all reagents in this test are under control and the test results are reliable. At this time, observe the sample cup 7;
[0043] Step 4) judging whether the patient has upper gastrointestinal bleeding according to the color in the sample cup 7 and the semi-quantitative colorimetric card 10, which is divided into qualitative detection and quantitative detection;
[0044] The qualitative test is: if it is displayed as colorless and transparent, it indicates that no hemoglobin is detected in the patient's sample, no blood components, and no upper gastrointestinal bleeding; if it is displayed as blue, it indicates that the patient's sample contains hemoglobin, blood components are detected, and the patient has upper gastrointestinal bleeding;
[0045] The quantitative test is as follows: if the color is similar to the concentration of 0.001 mmol / L, it is judged as "±", and the patient may have upper gastrointestinal bleeding; if the color is similar to the concentration of 0.01 mmol / L, it is judged as "+", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥5 mL, and the patient has positive fecal occult blood; if the color is similar to the concentration of 0.1 mmol / L, it is judged as "++", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥50 mL, and the patient can observe black stool; if the color is similar to the concentration of 1 mmol / L, it is judged as "+++", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥500 mL, and the patient has clinical manifestations such as vomiting blood, general fatigue, and hypotension; if the color is similar to the concentration of 10 mmol / L and above, it is judged as "++++", the patient has upper gastrointestinal bleeding, the amount of bleeding is ≥30% of the total blood volume, and the patient may be in shock at any time.
[0046] In this embodiment, the patient sample is the patient's vomitus, gastric juice or upper gastrointestinal tract lavage fluid.
[0047] The G4 chain is a classic nucleic acid structure formed by guanine through Hoogsteen hydrogen bonds. When the G4 chain specifically binds to heme (the G4 chain can bind to heme to form a special chemical structure, thereby obtaining the same catalytic function as horseradish peroxidase (HRP)), the complex obtains the same catalytic function as horseradish peroxidase (HRP), which can react with the substrate tetramethylbenzidine (TMB) with the participation of hydrogen peroxide (H2O2) to change TMB from yellow to blue. Heme is one of the main components in red blood cells, and the complex formed by it and the G4 chain has a catalytic function similar to HRP;
[0048] Therefore, applying the G4 chain to the detection kit for detecting upper gastrointestinal bleeding can solve the problem that the current clinical upper gastrointestinal bleeding detection method is missing and the alternative method has many interference factors, resulting in low reliability of the results. Compared with the colloidal gold detection of fecal occult blood in the prior art, the method of the present invention has more accurate detection results, avoids the influence of the acidic environment on the detection results, and can avoid the interference of multiple factors (the strong acidity of gastric juice destroys hemoglobin) on the colloidal gold monoclonal antibody method.
[0049] The detection kit of the present invention can be used as a semi-quantitative detection basis, and the specific judgment basis is as follows:
[0050] After catalytic reaction of 8 different concentration gradients of hemoglobin (0, 0.001, 0.01, 0.1, 1, 10, 100, 1000 mmol / L) and 10 mmol / L G4 chain, the color development result after the reaction was measured by a spectrophotometer at a wavelength of 430 nm. The test results are shown in Table 1 below:
[0051] Table 1 OD values of products after catalytic reaction between different concentrations of heme and G4 chains
[0052]
[0053] In Table 1, the P value determines the nature (correlation) and the r value determines the degree (closeness).
[0054] As can be seen from Table 1, as the hemoglobin concentration increases, the absorbance (OD) value of the reaction product also increases significantly. After the person correlation analysis, the R value of the two is 0.896, P < 0.01, which is significantly positively correlated. Therefore, the present invention can perform semi-quantitative analysis of hemoglobin based on the color of the reaction product.
[0055] Therefore, it is necessary to formulate a semi-quantitative grade basis in the detection kit of the present invention, and the specific process is as follows:
[0056] The normal whole blood hemoglobin concentration is about 7.5~10 mmol / L, and the residual volume of gastric juice is about 50 mL. Therefore, when the hemoglobin concentration in vomitus or gastric juice reaches 10 mmol / L, the corresponding bleeding volume = (10×50×10-3) / normal whole blood hemoglobin concentration, and the bleeding volume is about 50~66 mL. In order to facilitate clinical judgment, it is simplified to 50 mL, corresponding to the dilution (100 times dilution) Figure 2 The concentration in is 10-1 mmol / L, and the grade is "++". Then the possible bleeding amount corresponding to different hemoglobin concentrations is deduced in turn according to the dilution multiple, such as Figure 2 shown.
[0057] The method of using the above detection kit is as follows: Figure 1 , Figure 2 , Figure 3 As shown, the specific steps are as follows:
[0058] (1) Use sampling tube 3 to collect patient samples (vomitus, gastric juice, upper gastrointestinal tract lavage fluid, etc.), place the sample in sampling bottle 4 for dilution, take 50 μL of sample dilution solution and place it in the sample cup 7 to be tested, and at the same time take 50 μL of positive quality control reagent 9 and place it in the positive cup 8.
[0059] (2) Leave the sample cup 7 and the positive cup 8 at room temperature (25°C) for 30 min.
[0060] (3) Add 25 μL of reaction reagent 5 and 25 μL of colorimetric reagent 6 to the sample cup 7 and positive cup 8, respectively, and mix by pipetting for 15 min. If the positive cup 8 shows a dark blue color, it proves that all reagents in this test are under control and the test results are reliable. At this time, observe the sample cup 7.
[0061] (4) According to the color in the sample cup 7 to be tested, the final result is judged by comparing it with the semi-quantitative detection colorimetric card 10 to determine whether the patient has upper gastrointestinal bleeding:
[0062] (4-1) Qualitative test: If the test result is colorless and transparent, it indicates that no hemoglobin is detected in the patient's sample, no blood components are present, and no upper gastrointestinal bleeding occurs. If the test result is blue, it indicates that hemoglobin is present in the patient's sample, blood components are present, and the patient has upper gastrointestinal bleeding.
[0063] (4-2) Quantitative detection: If the color is close to the concentration of 0.001 mmol / L, it is judged as "weak positive (±)", and the patient may have upper gastrointestinal bleeding; if the color is close to the concentration of 0.01 mmol / L, it is judged as "+", and the patient has upper gastrointestinal bleeding, the amount of bleeding is about 5 mL, and fecal occult blood may be positive; if the color is close to the concentration of 0.1 mmol / L, it is judged as "++", and the patient has upper gastrointestinal bleeding, the amount of bleeding is about 50 mL, and the patient may observe black stool; if the color is close to the concentration of 1mmol / L, it is judged as "+++", and the patient has upper gastrointestinal bleeding, the amount of bleeding is about 500 mL, and the patient may have clinical manifestations such as vomiting blood, general fatigue, and hypotension if the bleeding amount is greater than 500 mL; if the color is close to the concentration of 10 mmol / L and above, it is judged as "++++", and the patient has upper gastrointestinal bleeding, the amount of bleeding reaches or exceeds 30% of the total blood volume, and the patient may be in shock at any time.
[0064] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. An upper gastrointestinal bleeding detection kit based on G4 chain and heme catalytic activity, characterized in that: include: A sampling device, the sampling device is composed of a sampling tube and a sampling bottle, and the sampling bottle contains Tris-EDTA buffer; A detection device, comprising a detection reagent, a reaction cup, a positive quality control reagent and a semi-quantitative detection colorimetric card; The detection reagent includes a reaction reagent and a color developing reagent, and the reaction reagent and the color developing reagent are respectively loaded in two detection reagent storage bottles; The reaction cup includes a sample cup to be tested and a positive cup, and the bottom of each cup is coated with a G4 chain unit, wherein the G4 chain unit is a DNA of a double G4 chain unit, and the DNA sequence thereof is 5'-AGGGTACCTAGGGTACCTA-3', as shown in SEQ ID NO: 1; The positive quality control reagent is a mixture of 100 μmol / L standard hemoglobin and 1 mmol / L Tris-EDTA buffer, which is loaded in a light-proof positive quality control bottle; The reaction reagent is H2O2 solution, and the color developing reagent is TMB solution.
2. The upper gastrointestinal bleeding detection kit based on G4 chain and heme catalytic activity according to claim 1, characterized in that: The semi-quantitative detection colorimetric card can display the color development results after 8 different concentration gradients of hemoglobin, 0, 0.001, 0.01, 0.1, 1, 10, 100, 1000 mmol / L, react with 10 mmol / L G4 chain body, as well as the corresponding bleeding equivalent, result grade and clinical description.
3. The upper gastrointestinal bleeding detection kit based on G4 chain and heme catalytic activity according to claim 2, characterized in that: The concentration of the Tris-EDTA buffer in the sampling bottle is 1 mmol / L; the concentration of the H2O2 solution is 5 mol / L; and the concentration of the TMB solution is 20 mmol / L.
4. The upper gastrointestinal bleeding detection kit based on G4 chain and heme catalytic activity according to claim 3, characterized in that: The volume of the reaction cup is 500 μL; the content of the G4 chain unit is 500 nmol; the content of the Tris-EDTA buffer in the sampling bottle is 990 μL.
